Invasive fungal infections after obinutuzumab monotherapy for refractory chronic lymphocytic leukemia

被引：0
|
作者：
Eric Tse
Rock Y. Y. Leung
Yok-Lam Kwong
机构：
[1] Queen Mary Hospital,Department of Medicine
[2] Queen Mary Hospital,Department of Pathology
来源：
Annals of Hematology | 2015年 / 94卷
关键词：
Chronic Lymphocytic Leukemia; Itraconazole; Alemtuzumab; Invasive Fungal Infection; Micafungin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：165 / 167
页数：2
相关论文
共 50 条
  • [1] Invasive fungal infections after obinutuzumab monotherapy for refractory chronic lymphocytic leukemia
    Tse, Eric
    Leung, Rock Y. Y.
    Kwong, Yok-Lam
    [J]. ANNALS OF HEMATOLOGY, 2015, 94 (01) : 165 - 167
  • [2] Obinutuzumab monotherapy in previously untreated chronic lymphocytic leukemia
    Gay, Nathan D.
    Kozin, Eliana
    Okada, Craig
    Danilov, Alexey V.
    Spurgeon, Stephen
    [J]. LEUKEMIA & LYMPHOMA, 2018, 59 (09) : 2258 - 2260
  • [3] High rates of proven invasive fungal disease with the use of ibrutinib monotherapy for relapsed or refractory chronic lymphocytic leukemia
    Teh, Benjamin W.
    Chui, William
    Handunnetti, Sasanka
    Tam, Constantine
    Worth, Leon J.
    Thursky, Karin A.
    Slavin, Monica A.
    [J]. LEUKEMIA & LYMPHOMA, 2019, 60 (06) : 1572 - 1575
  • [4] Fungal Infections in Chronic Lymphocytic Leukemia before and after Treatment
    Schoen, Martin W.
    Georgantopoulos, Peter
    Yalavarthi, Nagasai S.
    Bennett, Charles L.
    [J]. BLOOD, 2019, 134
  • [5] Obinutuzumab for chronic lymphocytic leukemia
    Rioufol, Catherine
    Salles, Gilles
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (05) : 533 - 543
  • [6] Obinutuzumab in chronic lymphocytic leukemia
    Dupuis, Jehan
    [J]. FUTURE ONCOLOGY, 2015, 11 (18) : 2503 - 2513
  • [7] Bendamustine monotherapy in advanced and refractory chronic lymphocytic leukemia
    Kath, R
    Blumenstengel, K
    Fricke, HJ
    Höffken, K
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2001, 127 (01) : 48 - 54
  • [8] Bendamustine monotherapy in advanced and refractory chronic lymphocytic leukemia
    R. Kath
    K. Blumenstengel
    H. J. Fricke
    K. Höffken
    [J]. Journal of Cancer Research and Clinical Oncology, 2001, 127 : 48 - 54
  • [9] OBINUTUZUMAB FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA
    Rogers, K. A.
    Jones, J. A.
    [J]. DRUGS OF TODAY, 2014, 50 (06) : 407 - 419
  • [10] Addition of rituximab in relapsed/refractory chronic lymphocytic leukemia after progression on venetoclax monotherapy
    Handunnetti, Sasanka
    Anderson, Mary Ann
    Roberts, Andrew W.
    Davids, Matthew S.
    Ma, Shuo
    Boyer, Michelle
    Arzt, Jennifer
    Al Masud, Abdullah
    Popovic, Relja
    Jacobson, Amanda
    Kim, Su Y.
    Seymour, John F.
    [J]. EJHAEM, 2021, 2 (02): : 266 - 271
12345